STP Modular Course

Course Objective

The objective of this STP Modular Education Course, “Toxicologic Pathology of the Reproductive System,” is to educate individuals on the principles of toxicology and pathology of the reproductive system. Attendees will gain a thorough introduction to the anatomy and physiology of the male and female reproductive systems in laboratory animal species with an emphasis on INHAND nomenclature. Additionally, the course will cover patterns of toxicity, the estrous cycle, reproductive senescence, proliferative findings, assessment of the juvenile reproductive system, and reviews of digital slides.

Course Chair

Pankaj Kumar, BVSc, MVSc, PhD, DACVP, AbbVie

Course Co-Chair

Anantharaman Muthuswamy, DVM, MS, PhD, DACVP, Genmab

Course Scientific Advisor

Justin Vidal, DVM, PhD , Charles River Laboratories

• J. Mark Cline, DVM, PhD, DACVP (Wake Forest School of Medicine)
• Sarah Coe, DVM, DACVP (Inotiv)
• Kiran S. Palyada, BVSc, MVSc, PhD, DACVP, DABT (Pfizer Inc.)
• Catherine A. Picut, VMD, JD, DABT, DACVP, FIATP (Charles River Laboratories)
• Karen S. Regan, DVM, DACVP, DABT (Regan Path/Tox Services)
• Mee Ja M. Sula, DVM, DACVP (Charles River Laboratories)
• Roy Wakefield, BVSc, FRCPath, MRCVS (Labcorp)
• Cynthia Willson, MS, PhD, DVM, DACVP, DABT (Inotiv)

Virtual

October 9–25, 2023

Continuing Education

This program (20-1097472) was approved for 19.50 hours of continuing education credits in jurisdictions that recognize RACE approval.

Course Objective

The objective of this STP Modular Education Course “Toxicologic Pathology of the Renal System” is to educate individuals in the principles of toxicology and pathology of the renal system. Attendees will gain a thorough introduction to the anatomy and physiology of the renal system in laboratory animal species with an emphasis on INHAND nomenclature. Additionally, the course will cover recent advances in the understanding biologic-associated immune mediated renal disease, biomarkers, emerging technologies (AI and organs-on-chips) and drug-induced injury.

Course Chair

Pankaj Kumar, BVSc, MVSc, PhD, DACVP, AbbVie

Course Co-Chair

Anantharaman Muthuswamy, DVM, MS, PhD, DACVP, Genmab

Course Scientific Advisors

Kathleen Heinz-Taheny, DVM, PhD, DABT, DACVP, Eli Lilly and Company
Kendall S. Frazier, DVM, PhD, DACVP, DABT, FIATP, Independent Consultant

Faculty

• Timothy W. Carlson, DVM, MS, DACVP, Charles River Laboratories
• Rachel Cianciolo, PhD, VMD, Zoetis Reference Labs
• Samuel M. Cohen, MD, PhD, University of Nebraska Medical Center
• Mary B. Nabity, DVM, PhD, DACVP, Texas A&M University
• Carrie L. Phillips, MD, Indiana University School of Medicine
• Ryan F. Relich, PhD, Indiana University School of Medicine
• Michael A. Ringenberg, DVM, PhD, DACVP, GlaxoSmithKline
• Daniel G. Rudmann, DVM, PhD, DACVP, Charles River Laboratories
• Marshall Scicchitano, MS, ProPharma Group
• John Curtis Seely, DVM, DACVP, EPL Inc.

Virtual

October 10–26, 2022

Continuing Education

This program (20-932062) was approved for 20.00 hours of continuing education credits in jurisdictions that recognize RACE approval.

Course Objective

The objective of this STP Modular Education Course “Toxicologic Pathology of Integumentary and Musculoskeletal Systems” is to educate individuals in the principles of toxicology and pathology of the integumentary and musculoskeletal systems. Attendees will gain a thorough introduction to both of the systems, as well as discussion on skin immunology and minipig models, sampling bones for toxicity studies and osteoarthritis, and muscle toxicity and biomarkers.

Course Chairs

Alok Sharma, BVSc, MVSc, MS, PhD, DACVP, DABT, Labcorp
Dimitry Danilenko, DVM, PhD, DACVP, Danilenko Nonclinical Drug Development, LLC
Kathryn Gropp, DVM, PhD, DACVP, Pfizer Inc.

Course Scientific Advisors

Lydia Andrews-Jones, DVM, PhD, DACVP, AbbVie
Kelly Diegel, DVM, PhD, DACVP, GlaxoSmithKline
John Vahle, DVM, PhD, DACVP, Eli Lilly and Company
Aurore Varela, DVM, MSc, DABT, Charles River Laboratories

Faculty

• Aneesh Alex, MSc, PhD, GlaxoSmithKline
• Alexandra Armstrong, DVM, DACVP, University of Minnesota
• Agathe Bédard, DVM, DACVP, Charles River Laboratories
• Rogely Boyce, DVM, PhD, DACVP, Amgen Consultant
• Maurice Cary, DVM, PhD, DACVP, Pathology Experts GmbH
• Luc Chouinard, DVM, DACVP, Charles River Laboratories
• Warren Glaab, PhD, Merck
• Solomon Haile, DVM, MVSc, PhD, DACVP, Charles River Laboratories
• Sara Santagostino, DVM, PhD, DACVP, Genentech
• Aaron Sargeant, DVM, PhD, DACVP, Charles River Laboratories
• Ryan Schafbuch, DVM, MS, DACVP, Charles River Laboratories

Virtual

October 11–27, 2021

Continuing Education

This program (20-880410) was approved for 18.50 hours of continuing education credits in jurisdictions which recognize RACE approval.

Course Objective

The objective of the STP Modular Course “Toxicologic Pathology of the Endocrine System” is to educate individuals in the principles of toxicology and pathology of the endocrine system. Attendees will gain a solid understanding of the normal anatomy and physiology of the endocrine system, rodent and non-rodent background and induced lesions, assessment of circulating hormones in toxicology studies, as well as discussion of endocrine disruption and modulation as a therapeutic target.

Course Chairs

Helen Booler, BVetMed, DECVP, PhD, MRCVS, Genentech
Alok Sharma, BVSc, MVSc, MS, PhD, DACVP, DABT, Covance

Course Scientific Advisors

Sundeep Chandra, BVSc, PhD, DACVP, Biomarin
Mark J. Hoenerhoff, DVM, PhD, DACVP, University of Michigan Medical School
Richard Peterson, II, DVM, PhD, DACVP, AbbVie
Thomas J. Rosol, DVM, PhD, MBA, DACVP, Ohio University Heritage College of Medicine

Faculty

• Noel Dybdal, DVM, PhD, Genentech
• Kevin Lee, PhD, Ohio University Heritage College of Medicine
• Daniel G. Rudmann, DVM, PhD, DACVP, Charles River Laboratories
• John L. Vahle, DVM, PhD, DACVP, Eli Lilly and Company
• Justin Vidal, DVM, PhD, Charles River Laboratories
• Dana B. Walker, DVM, DACVP, MS, PhD, Novartis Institutes of Biomedical Research
• Jeffrey C. Wolf, DVM, DACVP, EPL, Inc.
• Charles E. Wood, DVM, PhD, DACVP, Boehringer Ingelheim

Virtual

October 12–28, 2020

Continuing Education

This program (56-44028) has been approved for 21 hours of continuing education credits in jurisdictions which recognize RACE approval.

Course Objective

The objective of this STP Modular Education Course on the Toxicologic Pathology of Special Senses is to educate individuals in the principles of toxicology and pathology of the special senses, focusing on the pathologic evaluation of the ocular and otic systems. Attendees will gain a solid understanding of the normal anatomy and histology of the eye and associated structures, including both theory and practical classes of current accepted terminology through GoRENI, rodent and non-rodent ocular and otic pathology, physiology and function, study requirements to assess ocular and otic toxicity, as well as discussion of gene and cell-based therapies in the eye and ear.

Course Chairs

Tracy Carlson, DVM, PhD, DACVP, Charles River
Helen Booler, BVetMed, DECVP, PhD, MRCVS, Genentech, Inc.
Alok Sharma, BVSc, MVSc, MS, PhD, DACVP, DABT, Covance

Course Scientific Advisors

Ken Schafer, DVM, PhD, DACVP, Greenfield Pathology Services, Inc.
Bradley Njaa, DVM, MVSc, DACVP, Kansas State University

Faculty

• Joshua Bartoe, MS, DVM, Northern Biomedical Research
• Brad Bolon, DVM, MS, PhD, DACVP, DABT, FATS, FIATP, FRCPath, GEMpath
• Phaedra Cole, DVM, MS, DACVP, Zoetis
• Cindy Farman, DVM, PhD, DACVP, Farman Pathology
• Leslie Lemke-Boucher, PhD, DABT, Covance
• Meg Ramos, DVM, PhD, DACVP, AbbVie
• Brian Short, DVM, PhD, DACVP, Consultant
• Steve Sorden, DVM, PhD, Covance

Location

Hilton Indianapolis Hotel & Suites, Indianapolis, Indiana

Continuing Education

This program (56-38216) has been approved for 17.50 hours of continuing education credit in jurisdictions which recognize RACE approval.

Course Objective

The objective of this Society of Toxicologic Pathology (STP) modular course is to educate individuals in the principles of toxicology and pathology of the gastrointestinal and exocrine pancreas system. The STP course will brought together course attendees and world renowned subject experts for didactic lectures and practical sessions including whole-slide digital images and data sets. The course was held over three days in an environment that facilitates an intensive learning experience.

Course Directors

Tracy Carlson, DVM, PhD, DACVP, MPI Research
Melissa Schutten, DVM, PhD, DACVP, Genentech, Inc.

Faculty

• Dr. Anthony Bahinski, GlaxoSmithKline
• Dr. Ingrid Bergin, University of Michigan
• Dr. Molly Boyle, Envigo++++
• Dr. Julia Cui, University of Washington
• Dr. Lauri Diehl, Genentech, Inc.
• Dr. Jason Ekert, GlaxoSmithKline
• Dr. Warren Glaab, Merck, Inc. (West Point)
• Dr. Carole Harbison, Takeda Pharmaceuticals
• Dr. Rie Kikkawa, Novartis
• Dr. Steven Laing, Genentech, Inc.
• Dr. Sunish Mohanan, GlaxoSmithKline
• Dr. Leah Schutt, Genentech, Inc.
• Dr. Rani Sellers, Pfizer
• Dr. Andrew Suttie, Covance
• Dr. Jerry Ward, Consultant
• Dr. John Vahle, Eli Lilly and Company

Location

Chauncey Conference Center, Princeton, New Jersey

Continuing Education

This program (56-34344) is approved by the AAVSB RACE to offer a total of 17.50 CE Credits (17.50 max) being available to any one veterinarian: and/or 17.50 Veterinary Technician CE Credits (17.50 max). This RACE approval is for the subject matter categories of: Category One: Scientific Category Two: Non-Scientific-Clinical using the delivery method of Seminar/Lecture. This approval is valid in jurisdictions which recognize AAVSB RACE; however, participants are responsible for ascertaining each board’s CE requirements. RACE does not “accredit” or “endorse” or “certify” any program or person, nor does RACE approval validate the content of the program.

Course Objective

The objective of this Society of Toxicologic Pathology (STP) modular course is to educate individuals in the principles of toxicologic pathology of the respiratory system.

Course Description

The STP course brought together attendees and world renowned subject experts for didactic lectures and practical sessions including whole-slide digital images and data sets. The course was held over three days in an environment that facilitates an intensive learning experience. Practical evaluation and interpretation of toxicologic pathology data was emphasized.

Faculty

• Course Director: Paula Katavolos, DVM, PhD (Genentech)
• Course Director: Melissa Schutten, DVM, PhD, DACVP (Genentech)
• Molly Boyle, DVM, MPH, DACVP (Envigo)
• Michael DeLorme, PhD (3M)
• Reina Fuji, VMD, PhD, DACVP (Genentech)
• Andrew Gigliotti, DVM, PhD, DACVP (Lovelace Respiratory Research Institute)
• Jack Harkema, DVM, PhD, DACVP (Michigan State University)
• Philip Kuehl, PhD (Lovelace Respiratory Research Institute)
• Nicholas Macri, DVM, MS, PhD (Envigo)
• David Meyerholz, DVM, PhD (University of Iowa)
• Kathila Rajapaska, PhD (Genentech)
• Dan Rudmann, DVM, PhD, DACVP (Flagship Biosciences, Inc.)
• Dennis Wilson, DVM, PhD, DACVP (University of California, Davis)

Location

The Hotel Minneapolis, Minneapolis, Minnesota

Continuing Education

This program was submitted for continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some regulatory boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

Course Objective

The objective of this Society of Toxicologic Pathology (STP) Modular Education course is to educate individuals in the principles of toxicologic pathology of the hepatobiliary system.

Course Description

The STP course will bring together course attendees and world renowned subject experts for didactic lectures and practical sessions including whole-slide digital images and data sets. The course will be held over three days in an environment that facilitates an intensive learning experience. Practical evaluation and interpretation of toxicologic pathology data will be emphasized.

Faculty

• Course Director: Sunish Mohanan, PhD, DACVP (Eli Lilly and Company)
• Russell Cattley, VMD, PhD (Auburn University)
• John Cullen, VMD, PhD, DACVP (North Carolina State University)
• Daniela Ennulat, DVM, PhD (GlaxoSmithKline)
• Robert Johnson, DVM, PhD (Novartis)
• Gregory Kedderis, PhD (Consultant)
• David Malarkey, DVM, PhD, DACVP (National Institute of Environmental Health Sciences)
• Bob Maronpot, DVM (Maronpot Consulting, LLC)
• Richard Miller, DVM, PhD (GlaxoSmithKline)
• Shashi Ramaiah, DVM, PhD, DACVP, DABT (Pfizer)
• Jerry Ward, DVM, PhD, DACVP (Global Vet Pathology)
• Paul Watkins, MD (University of North Carolina Chapel Hill)

Location

Embassy Suites Raleigh-Durham, Raleigh, North Carolina

Continuing Education

This program will be submitted for continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some regulatory boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

Course Objective

The objective of this Society of Toxicologic Pathology (STP) modular course is to educate individuals in the principles of toxicologic pathology of the cardiovascular system.

Course Description

The STP course will bring together course attendees and world renowned subject experts for didactic lectures and practical sessions including whole-slide digital images and data sets. The course will be held over three days in an environment that facilitates an intensive learning experience. Practical evaluation and interpretation of toxicologic pathology data will be emphasized.

Faculty

• Course Director: Schantel A. Bouknight, DVM, PhD, DACVP (Charles River Laboratories)
• Course Director: Tanja S. Zabka, DVM, DACVP, DSP (Genentech)

Location

Hilton San Francisco Financial District, San Francisco, California

Continuing Education

This program 56-23891 is approved by the AAVSB RACE to offer a total of 21.00 CE Credits (21.00 max) being available to any one veterinarian: and/or 21.00 Veterinary Technician CE Credits (21.00 max). This RACE approval is for the subject matter categorie(s) of: Category One: Scientific Category Two: Non-Scientific-Clinical using the delivery method(s) of: Seminar/LectureLab/Wet Lab. This approval is valid in jurisdictions which recognize AAVSB RACE; however, participants are responsible for ascertaining each board's CE requirements.

Course Objective

The objective of this Society of Toxicologic Pathology (STP) Modular Education course is to educate individuals in the principles of toxicologic pathology of the immune system.

Course Description

The STP course will bring together course attendees and world renowned subject experts for didactic lectures and practical sessions including whole-slide digital images and data sets. The course will be held over three days in an environment that facilitates an intensive learning experience. Practical evaluation and interpretation of toxicologic pathology data will be emphasized.

Faculty

• Course Director: George A. Parker, DVM, PhD, DACVP, DABT (WIL Research)
• David Caudell, DVM, PhD (Wake Forest University)
• Susan A. Elmore, MS, DVM, DACVP, DABT (NTP/NIEHS)
• Ellen Evans, DVM, PhD, DACVP (Pfizer, Inc.)
• Dori R. Germolec, PhD (NIEHS)
• Norbert Makori, PhD (WIL Research)
• Tracey L. Papenfuss, MS, DVM, PhD, DACVP (WIL Research)
• Richard Peterson, II, DVM, PhD, DACVP (GlaxoSmithKline)
• Jerold Rehg, DVM (Saint Jude Children’s Research Hospital)
• Paul Snyder, DVM, PhD, DACVP (EPL, Inc.)
• Jerrold M Ward, DVM, PhD, DACVP (Veterinary Pathologist)
• Cynthia Willard-Mack, VMD, PhD (Huntingdon Life Sciences)

Location

Raleigh, North Carolina

Continuing Education

This program has been approved for 18.5 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some regulatory boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

Course Objective

The objective of this Society of Toxicologic Pathology (STP) Modular Education course is to educate individuals in the principles of toxicologic pathology of the reproductive system.

Course Description

This course is modeled on the highly regarded and successful British Society of Toxicological Pathology (BSTP) Modular Education courses. Similar to the BSTP courses, the STP course will bring together course attendees and world renowned subject experts for didactic lectures and practical sessions including whole-slide digital images and data sets. The course will be held over three days in an environment that facilitates an intensive learning experience. Practical evaluation and interpretation of toxicologic pathology data will be emphasized.

Faculty

• Course Co-Director: Bhanu Singh, BVSc, MS, DACVP, DABT, FIATP (Janssen Research & Development)
• Course Co-Director: George A. Parker, DVM, PhD, DACVP, DABT (WIL Research)
• Karyn Colman, BVetMed, MRCVS (Novartis Institute for Biomedical Research)
• Dianne M. Creasy, PhD, FRCPath (Huntingdon Life Sciences)
• Ronald Herbert, DVM, PhD (National Institute of Environmental Health Sciences)
• Catherine A. Picut, VMD, JD, DACVP, DABT (WIL Research)
• Justin D. Vidal, DVM, PhD, DACVP (GlaxoSmithKline)

Location

Chauncey Conference Center, Princeton, New Jersey

Continuing Education

This program has been approved for 22.5 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

Course Objective

The Society of Toxicologic Pathology (STP) is offering the inaugural course in the Modular Education Series which will focus on Neuropathology. The first course is planned in partnership with the British Society of Toxicological Pathology (BSTP) and with help from the STP Special Interest Group in Neuropathology (SIGN).

Course Description

The BSTP has offered a Modular Education Series for many years offering two to three courses a year focusing on specific organ systems. In bringing these modular courses to the United States, the STP will offer these same opportunities to pathologists who might not otherwise be able to attend those offered by the BSTP. These courses will include both didactic lectures and practical data and slide review sessions. Microscopic evaluation of histologic sections will be done using whole-slide digital pathology images and practical evaluation/interpretation of toxicologic pathology data will be emphasized.

Faculty

• Course Director: Mark T. Butt, DVM, DACVP (Tox Path Specialists)
• Ken Schafer, DVM, PhD, DACVP (Vet Path Services)
• Carrie Markgraf, MD, PhD (Merck & Co. Ltd.)
• Alok Sharma, BVSc, MVSc, MS, PhD, DACVP, DABT (Covance Laboratories, Inc.)
• Jim Morrison, DVM, DACVP (Charles River Laboratories, Pathology Associates)
• Robert H. Garman, DVM, DACVP (Consultants in Veterinary Pathology)
• Ingrid D. Pardo, DVM, MS, DACVP (Pfizer, Inc.)

Location

Chauncey Conference Center, Princeton, New Jersey

Continuing Education

This program has been submitted (but not yet approved) for 21 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.